Article and Video CATEGORIES
Denise has over 30 years of varying experience in the healthcare arena. In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees. She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.
Did you know that current GRACE programs can be accessed under our EDUCATE navigation bar?
If you want to keep up on what content GRACE is producing, or if there is a specific program you are interested in seeing throughout the years, there are many ways to find that information. One of the best tools is the navigation drop-down under EDUCATE.
So much important information lives on the GRACE website, we are often finding that keeping everyone up to date on what information is available can be a daunting task! The list of programs under the EDUCATE dropdown will continue to grow and keep the most up-to-date, edited information available for our community.
Another excellent place to find the newest GRACE information is our YouTube channel, found at https://www.youtube.com/GRACE4cancerinfo. We also are always happy to answer a question through our Forums, available at https://cancergrace.org/forums.
Last but not least, you can search for information on the GRACE site via the search box in the upper right corner!
And of course for questions or concerns, please contact us through our contact form at https://cancergrace.org/contact.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...
Recent Comments
That's…